Asthmatic Patients
9
1
1
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
1 terminated out of 9 trials
83.3%
-3.2% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
Evaluation of Nasal Biomarkers for Objective Assessment of Disease Severity in Respiratory Disorders
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-4597 Inhalation in Healthy Subjects and Asthmatic Patients
Asthma Control Through Telemedicine
Assessment of Emergency Spacers Versus Traditional Spacers for Delivery of Aerosolized Drugs
Changes in FeNO Value During Pulmonary Rehabilitation in Patients with Asthma
Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 4.
FACTO Study (Foster® As Complete Treatment Option)
Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 3
Social-Economics Profile of the Asthmatic Patients Attended at Nucleus of Integrated Medical Care